Authors:
Nakajima, A
Nakajima, F
Shimizu, S
Ogasawara, A
Wanaka, A
Moriya, H
Einhorn, TA
Yamazaki, M
Citation: A. Nakajima et al., Spatial and temporal gene expression for fibroblast growth factor type I receptor (FGFR1) during fracture healing in the rat, BONE, 29(5), 2001, pp. 458-466
Authors:
Gerstenfeld, LC
Cho, TJ
Kon, T
Aizawa, T
Cruceta, J
Graves, BD
Einhorn, TA
Citation: Lc. Gerstenfeld et al., Impaired intramembranous bone formation during bone repair in the absence of tumor necrosis factor-alpha signaling, CELLS T ORG, 169(3), 2001, pp. 285-294
Authors:
Kon, T
Cho, TJ
Aizawa, T
Yamazaki, M
Nooh, N
Graves, D
Gerstenfeld, LC
Einhorn, TA
Citation: T. Kon et al., Expression of osteoprotegerin, receptor activator of NF-kappa B ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracturehealing, J BONE MIN, 16(6), 2001, pp. 1004-1014
Authors:
Nakajima, F
Ogasawara, A
Goto, K
Moriya, H
Ninomiya, Y
Einhorn, TA
Yamazaki, M
Citation: F. Nakajima et al., Spatial and temporal gene expression in chondrogenesis during fracture healing and the effects of basic fibroblast growth factor, J ORTHOP R, 19(5), 2001, pp. 935-944
Authors:
Einhorn, TA
Nielsen, GP
Rosenthal, DI
Scully, RE
Hornicek, FJ
Citation: Ta. Einhorn et al., A 26-year-old man with a mass in the knee. Biphasic synovial sarcoma, intraarticular., N ENG J MED, 344(2), 2001, pp. 124-131
Citation: Ta. Einhorn, In-reference to sources: Peer-reviewed vs. non-peer-reviewed articles, proceedings, and unpublished data - Reply, J BONE-AM V, 83A(9), 2001, pp. 1432-1432
Citation: Ta. Einhorn, Sheep model for fracture treatment in osteoporotic bone: A pilot study about different induction regimens - Commentary, J ORTHOP TR, 14(8), 2000, pp. 565-566
Citation: Ta. Einhorn, Recombinant human bone morphogenetic protein-2 overcomes the inhibitory effect of ketorolac, a nonsteroidal anti-inflammatory drug (NSAID), on posterolateral lumbar intertransverse process spine fusion - Point of view, SPINE, 24(21), 1999, pp. 2193-2194